one or more non free copyrighted sources . ideas in this article should be expressed in an original manner . more details may be available on the talk page . january 2016 learn how and when to remove this template message asuragen is a global diagnostic products company delivering solutions that build knowledge and understanding of complex clinical questions . asuragen s application of its deep scientific heritage and molecular expertise delivers diagnostic products in oncology and genetics that provide the best answers with optimal workflows so time can be spent delivering actionable insights rather than searching for them . with innovative approaches to kit development and a broad range of molecular chemistries asuragen produces assays that ensure reproducible results . from discovery and development to regulatory support to global commercialization they also provide a tailored approach that efficiently delivers custom and companion diagnostic products for their partners . asuragen industry biotechnology founded march 2006 2006 03 headquarters austin texas united states divisions diagnostics translational diagnostics website http www.asuragen.com contents 1 diagnostics 2 services 3 clinical reference laboratory 4 asuragen patents 5 history 6 references diagnostics edit offerings includes molecular diagnostic products providing identification of genetic abnormalities associated with oncology and genetic diseases . multiplex assay oncology tests for leukemia including abnormalities associated with cml bcr abl all apl aml npm1 rna stabilization products with its armored rna technology and a genetic test amplidex 1 and software 2 for fragile x mental retardation fmr1 . 3 services edit rna related services including analyst isolation preparation from multiple sample types genomic profiling mirna mrna expression profiling biomarker discovery assay design and validation clia based clinical testing bioinformatic analysis and regulatory and project management services . 4 clinical reference laboratory edit the laboratory is clinical laboratory improvement amendment clia certified and college of american pathology cap accredited . clinical laboratory testing services include xpansion interpreter which utilizes novel pcr technology to comprehensively genotype the 5 region of the fmr1 gene in order to assess the risk of expansion in future generations . 5 asuragen patents edit methods and compositions involving microrna the following present inventions concern methods and compositions for isolating enriching and or labeling mirna molecules and for preparing and using arrays or other detection techniques for mirna analysis . moreover the present invention concerns methods and compositions for generating mirna profiles and employing such profiles for therapeutic diagnostic and prognostic applications.patent no. 7888010 issued 02 15 2011 patent no. 8003320 issued 08 23 2011 patent no. 7919245 issued 04 05 2011 patent no. 8058250 issued 11 15 2011 patent no. 7993831 issued 08 09 2011 ribonuclease resistant viral rna standards the following present inventions are directed to the process of creating a recombinant nucleic acid standard which is resistant to ribonuclease digestion and is non infectious . these armored rna standards are ideal as rna standards for the quantification of rna viruses such as hiv and hcv from human body fluids such as blood and cerebrospinal fluid . patent no. 5677124 issued 010 14 1997 patent no. 5919625 issued 07 06 1999 ribonuclease resistant rna preparation and utilization the following present inventions relate to nuclease resistant nucleic acids in general and ribonuclease resistant rnas in particular . methods of making and using such nucleic acids are disclosed . patent no. 5939262 issued 08 17 1999 patent no. 6214982 issued 04 10 2001 patent no. 6399307 issued 06 04 2001 patent no. 7033749 issued 04 25 2006 6 history edit in 1989 ceo cso and founder dr. matt winkler left his position as an associate professor of zoology at the university of texas and formed a molecular biology reagent company called ambion . winkler then formed asuragen from ambion s molecular diagnostics and pharmacogenomic service divisions following the march 2006 sale of the research products division of ambion inc. to the applied biosystems group currently life technologies . 7 in december 2007 the microrna therapeutics activities were moved into a new entity called mirna therapeutics . 8 references edit amplidex fmr1 asuragen . asuragen . retrieved 2016 01 05 . automated software solution for accurate sizing of the fmr1 cgg repeat region november 5 2013 seldon johathan may 28 2006 49m in venture funds bring asuragen to life austin business journal pp . d2 d4 seldon johathan may 28 2006 49m in venture funds bring asuragen to life austin business journal pp . d2 d4 filipovic sadic . a novel fmr1 pcr method for the routine detection of low abundance expanded alleles and full mutations in fragile x syndrome . . asuragen inc. granted patents rockwell lily december 10 2007 asuragen gets push forward austin american statesman pp . d2 d4 harrington kate january 18 24 2008 asuragen launches new microrna firm austin business journal pp. 3 7 retrieved from https en.wikipedia.org w index.php title asuragen & oldid 743722938 categories organizations established in 2006companies based in austin texaspharmacologyhidden categories articles needing cleanup from january 2016all pages needing cleanuparticles with close paraphrasing from january 2016all articles with close paraphrasing navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page print export create a bookdownload as pdfprintable version languages add links this page was last modified on 10 october 2016 at 21 57 . text is available under the creative commons attribution sharealike license ; additional terms may apply . by using this site you agree to the terms of use and privacy policy . wikipedia is a registered trademark of the wikimedia foundation inc. a non profit organization . privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view